PortalPublikationenCorrection: Overall survival and adverse events after treatm...

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

  • Mike Wenzel (Geteilte/r Erstautor/in)
  • Luigi Nocera (Geteilte/r Erstautor/in)
  • Claudia Collà Ruvolo
  • Christoph Würnschimmel
  • Zhe Tian
  • Shahrokh F Shariat
  • Fred Saad
  • Derya Tilki
  • Markus Graefen
  • Luis A Kluth
  • Alberto Briganti
  • Philipp Mandel
  • Francesco Montorsi
  • Felix K H Chun
  • Pierre I Karakiewicz

Beteiligte Einrichtungen

Bibliografische Daten

OriginalspracheEnglisch
ISSN1365-7852
DOIs
StatusVeröffentlicht - 12.2023
PubMed 36899091